Sundar Jagannath Reveals Promising CARTITUDE-1 Results

Source: Sundar Jagannath Shares Long-Term CARTITUDE-1 Results on CAR T-Cell Therapy for Multiple Myeloma - Mount Sinai Department of Medicine (2025-06-28)

Sundar Jagannath has shared encouraging long-term results from the CARTITUDE-1 clinical trial, which focuses on CAR T-cell therapy for treating multiple myeloma. The findings highlight the potential of this innovative treatment to improve patient outcomes and offer new hope for those battling this blood cancer. The update comes from Mount Sinai's Department of Medicine and underscores the ongoing advancements in immunotherapy. As research continues, these promising results could pave the way for broader adoption of CAR T-cell therapy in multiple myeloma management.

More recent coverage

• Orlando Bloom's Romantic Journey Through the Years
• Sean Combs' Son Kanye West Gains Independence
• Fragile Ceasefire Holds Between Iran and Israel
• Kristi Noem Allegedly Took Personal Cut of Donations
• Nephew Addresses Trump Dementia Concerns
• Mexico and Saudi Arabia Face Off in Gold Cup Quarterfinals
• Katy Perry and Orlando Bloom End Nearly Decade-Long Relationship
• Playing Minecraft on an E-Reader: A Surprising Challenge
• LAFC and Olivier Giroud End Their Partnership